Phospho-Akt1 (Ser473) antibody | knockout validation | Cell Signaling 9018

This is a knockout-validated antibody summary, based on the publication "AKT isoform-specific expression and activation across cancer lineages", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Phospho-Akt1 (Ser473) antibody | knockout validation | Cell Signaling 9018 figure 1
Figure 1. Western blot of AKT1 and pAKT1 in HCT116 parental, AKT2−/−, and AKT1−/− cells serum starved overnight and treated (or not treated) with insulin (20 μg/ml) for 30 min. ERK immunoblotting showed equivalent loading. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: Phospho-Akt1 (Ser473)

Catalog number: 9018

Summary: Rabbit monoclonal IgG a synthetic phosphopeptide corresponding to residues surrounding Ser473 of human Akt1 protein. Reacts with human, mouse and rat. Suitable for western blot, immunoprecipitation, immunofluorescence/immunocytochemistry, and flow cytometry.

Validation Method

Western blot

Sample

HCT116 parental, AKT2−/−, and AKT1−/− cells. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate), supplemented with protease inhibitor and phosphatase inhibitor cocktails (Pierce Biotechnology, Rockford, IL).

References
  1. Wang J, Zhao W, Guo H, Fang Y, Stockman S, Bai S, et al. AKT isoform-specific expression and activation across cancer lineages. BMC Cancer. 2018;18:742 pubmed publisher